Literature DB >> 25322926

Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study.

Hee Kyung Park1, Seong Hye Choi2, Sun A Park3, Hwa Jung Kim4, Yunhwan Lee5, Seol-Heui Han6, Eun-Joo Kim7, Byeong C Kim8, Hyun Jeoung Han9, So Young Moon10, Dong Won Yang11, Kyung Won Park12, Kee Hyung Park13, Bora Yoon14, Sang Won Seo15, Duk L Na15, Hae Ri Na16, Jae-Hong Lee17.   

Abstract

BACKGROUND &
OBJECTIVE: Early-onset Alzheimer's disease (EOAD, onset age < 65 years) may differ from late-onset Alzheimer's disease (LOAD) in terms of cognitive profiles and neuropsychiatric symptoms. There have been few studies for Korean EOAD patients using well-structured databases. Previous studies focusing on cognitive profiles between the two groups had a variety of demographic data and comparability. The purpose of this study was to identify the unique profiles of cognitive functions and neuropsychiatric symptoms in Korean EOAD patients that differentiate from LOAD.
METHODS: Through propensity score matching, a total of 435 patients with EOAD and a total of 435 patients with LOAD were included in this nationwide, multicenter, hospital-based study. Each patient underwent comprehensive neurological examination, interview for caregiver, neuropsychological tests, and brain magnetic resonance imaging.
RESULTS: Neuropsychological test results showed worse performances on frontal/executive functions, visuospatial function, and visual memory in EOAD patients as compared to LOAD patients. In terms of neuropsychiatric symptoms, apathy was more common in EOAD patients, while delusions were more prevalent in LOAD patients. The differences in neuropsychiatric symptoms between the two groups were most pronounced in patients with the APOE ε4 allele, suggesting that neuropsychiatric symptoms in AD may be influenced by the APOE genotype.
CONCLUSION: Our results suggested that EOAD may be an important phenotype, fronto-parietal dysfunction, in the spectrum of AD, and this finding can provide for early diagnosis of EOAD patients.

Entities:  

Keywords:  APOE genotype; Alzheimer's disease; early-onset dementia; nulticenter study

Mesh:

Substances:

Year:  2015        PMID: 25322926     DOI: 10.3233/JAD-141011

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

1.  State of the Science: Apathy As a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

Authors:  Lauren Massimo; Helen C Kales; Ann Kolanowski
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

2.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

Review 3.  Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.

Authors:  Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella
Journal:  Nurs Outlook       Date:  2017-06-16       Impact factor: 3.250

Review 4.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

5.  The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.

Authors:  Neus Falgàs; Isabel E Allen; Salvatore Spina; Harli Grant; Stefanie D Piña Escudero; Jennifer Merrilees; Rosalie Gearhart; Howard J Rosen; Joel H Kramer; William W Seeley; Thomas C Neylan; Bruce L Miller; Gil D Rabinovici; Lea T Grinberg; Christine M Walsh
Journal:  Eur J Neurol       Date:  2021-12-20       Impact factor: 6.288

6.  Early and late-onset Alzheimer's disease: What are the differences?

Authors:  Adnan A Awada
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

7.  A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.

Authors:  Seong Soo An; Sun Ah Park; Eva Bagyinszky; Sun Oh Bae; Yoon-Jeong Kim; Ji Young Im; Kyung Won Park; Kee Hyung Park; Eun-Joo Kim; Jee Hyang Jeong; Jong Hun Kim; Hyun Jeong Han; Seong Hye Choi; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-12-15       Impact factor: 4.458

8.  SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease.

Authors:  Sun Ah Park; Jin Myung Jung; Jun Sung Park; Jeong Ho Lee; Bumhee Park; Hyung Jun Kim; Jeong-Ho Park; Won Seok Chae; Jee Hyang Jeong; Seong Hye Choi; Je-Hyun Baek
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

9.  Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data.

Authors:  Min Ju Kang; Sang Yun Kim; Duk L Na; Byeong C Kim; Dong Won Yang; Eun-Joo Kim; Hae Ri Na; Hyun Jeong Han; Jae-Hong Lee; Jong Hun Kim; Kee Hyung Park; Kyung Won Park; Seol-Heui Han; Seong Yoon Kim; Soo Jin Yoon; Bora Yoon; Sang Won Seo; So Young Moon; YoungSoon Yang; Yong S Shim; Min Jae Baek; Jee Hyang Jeong; Seong Hye Choi; Young Chul Youn
Journal:  BMC Med Inform Decis Mak       Date:  2019-11-21       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.